Showing posts with label tetracycline. Show all posts
Showing posts with label tetracycline. Show all posts

Tuesday, November 06, 2012

Antibiotic Resistance Killing Off Bees

Antibiotic Resistance Killing Off Bees


Yale researchers have identified a potential culprit in a nationwide increase of honeybee deaths — resistance to an important antibiotic.
In the Oct. 30 issue of the mBio journal, Yale professor of ecology and evolutionary biology Nancy Moran published a study showing that beneficial bacteria found in the guts of honeybees have acquired genes that make bees resistant to tetracycline, an antibiotic used to prevent colony-destroying infections and other bacterial diseases. Moran’s research identified eight tetracycline-resistant genes in American honeybees that were absent in honeybee populations where such antibiotic treatment is banned, suggesting that use of tetracycline has genetically altered beneficial bacteria and made colonies more prone to infection.
“We noticed that the [first] colony collapses happened in 2006, which is when the antibiotic was first introduced,” Moran told the News. “But it’s really a very speculative concept right now.”
Researchers in Moran’s lab are looking to confirm the link they have established between antibiotics and colony collapses so as to impact policy-making in the beekeeping community.
“The beekeepers are interested in healthy bees. If we can show that antibiotics affect honey production or colony survival, we can draw their attention,” Moran said.
To test bee genes for resistance to antibiotics, researchers in Moran’s lab isolated all of the bacterial DNA in bee guts and transferred them into independent DNA molecules called plasmids. These plasmids were then put into E. coli and sequenced so that the tetracycline-resistant genes could be identified. To determine how different bee populations interact with antibiotics, researchers used a technique called polymerase chain reaction to amplify bee DNA samples collected from various locations in the United States, New Zealand, the Czech Republic and Switzerland.
“We found that bees from the USA, which had a long treatment history [with tetracycline], carried the most resistant genes,” said Waldan Kwong GRD ’16, one of the authors of the paper and a researcher in Moran’s lab.
If confirmed, Moran’s research could have wide-reaching impact on American crop growth and production. Honeybee pollination plays a critical role in the $15 billion U.S. agriculture industry. The industry has been plagued by recent bee colony collapses, due primarily to bees’ contraction of the bacterial disease foul brood.
University of California, Davis apiculture professor Norman Gary stressed the magnitude of the colony collapse disorder.
“Only recently has the true value of honeybees been appreciated by people in this country,” Gary told the News. “The colony collapse disorder is a complex issue and many scientists are advancing theories to explain its cause.”
Kwong said he hopes the research conducted in Moran’s lab will encourage beekeepers to exercise caution when introducing new antibiotics into bee colonies.
“Beekeepers and the general public should be aware that application of antibiotics not only affects pathogens but also the normal healthy microbes that coexist with the host,” he said. He added, however, that further research and consultation with the beekeeping community are needed before any new policies can be introduced and implemented.
Gary said bee die-offs are likely the result of multiple factors rather than a single central cause. “In the scientific community we’re hoping that honeybees will develop a resistance to the cause of the colony collapses,” he said.
Moving forward, researchers in Moran’s lab are studying the health benefits and hazards posed by gut bacteria in bees. They are studying the microbes that have become resistant to tetracycline to understand the beneficial functions they perform, such as pathogen defense, as well as the negative impact they can have on bees’ immune systems.
“We want to understand how bacteria function in bees,” Moran said. Her lab is currently working on an experiment that exposes bees to antibiotics and analyzes their long-term effects. Though she said the team has evidence that bacteria can help bees digest food, Moran said they hope to discover other health benefits bacteria provide bees.
“It’s basic work, but nothing like it has ever been done before,” she said.
The lead author of the paper was former Yale postdoctoral researcher Baoyu Tian, and other authors included Yale researchers Nibal H. Fadhil and J. Elijah Powell. The research was funded through a grant from the National Science Foundation.

Monday, September 28, 2009

Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290.

Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290.

J Food Prot. 2009 Sep

Probiotics Research Department, Research Institute, Kagome Company, Limited, 17 Nishitomiyama, Nasushiobara, Tochigi, 329-2762, Japan. Masanori_Fukao@kagome.co.jp

Our purpose was to investigate the safety of the probiotic strain Lactobacillus brevis KB290. The European Qualified Presumption of Safety (QPS) evaluation approach was applied to the strain. We determined the strain's antibiotic resistance, verified it at the genetic level, and determined whether it could be transferred to intestinal microflora. Of 14 antibiotics tested, 11 showed MICs within the limits of the QPS criteria. However, the L. brevis KB290 MICs of ciprofloxacin (a fluoroquinolone), tetracycline, and vancomycin were two, four, and eight times, respectively, the breakpoint MICs suggested by the European Scientific Committee on Animal Nutrition, and the MIC of tetracycline was eight times the breakpoint MIC suggested by the European Scientific Panel on Additives and Products or Substances Used in Animal Feed. Using analysis of gapped-genome sequences, we found no known transferable determinants for tetracycline or vancomycin resistance, and we found no mutations in the quinolone resistance-determining regions of the genes encoding GyrA or ParC for ciprofloxacin resistance associated with insertion sequences, integrons, or transposons. These data were confirmed by using PCR primers specific for the respective genes. We assessed the transferability of the resistance traits in conjugation experiments with enterococci and obtained no transconjugants, strongly suggesting that the resistance traits were not transferable. This study demonstrated that the antibiotic resistance observed in L. brevis KB290 was due not to dedicated mechanisms but to intrinsic resistance. According to the QPS criteria, these results provide safety assurance for the ongoing use of L. brevis KB290 as a probiotic.

PMID: 19777895 [PubMed - in process]

Sunday, May 06, 2007

Antibiotic Treatment of the Tick Vector Amblyomma americanum Reduced Reproductive Fitness.

Antibiotic Treatment of the Tick Vector Amblyomma americanum Reduced Reproductive Fitness.

PLoS ONE. 2007 May

Zhong J,
Jasinskas A,
Barbour AG.
Department of Microbiology and Molecular Genetics, Department of Medicine and Pacific-Southwest Center for Biodefense and Emerging Infections, University of California Irvine, Irvine, California, United States of America.


BACKGROUND: The lone star tick Amblyomma americanum is a common pest and vector of infectious diseases for humans and other mammals in the southern and eastern United States. A Coxiella sp. bacterial endosymbiont was highly prevalent in both laboratory-reared and field-collected A. americanum. The Coxiella sp. was demonstrated in all stages of tick and in greatest densities in nymphs and adult females, while a Rickettsia sp. was less prevalent and in lower densities when present.

METHODOLOGY/PRINCIPAL FINDINGS: We manipulated the numbers of both bacterial species in laboratory-reared A. americanum by injecting engorged nymphs or engorged, mated females with single doses of an antibiotic (rifampin or tetracycline) or buffer alone. Burdens of the bacteria after molting or after oviposition were estimated by quantitative polymerase chain reaction with primers and probes specific for each bacterial species or, as an internal standard, the host tick. Post-molt adult ticks that had been treated with rifampin or tetracycline had lower numbers of the Coxiella sp. and Rickettsia sp. and generally weighed less than ticks that received buffer alone. Similarly, after oviposition, females treated previously with either antibiotic had lower burdens of both bacterial species in comparison to controls. Treatment of engorged females with either antibiotic was associated with prolonged time to oviposition, lower proportions of ticks that hatched, lower proportions of viable larvae among total larvae, and lower numbers of viable larvae per tick. These fitness estimators were associated with reduced numbers of the Coxiella sp. but not the Rickettsia sp.

CONCLUSION/SIGNIFICANCE: The findings indicate that the Coxiella sp. is a primary endosymbiont, perhaps provisioning the obligately hematophagous parasites with essential nutrients. The results also suggest that antibiotics could be incorporated into an integrated pest management plan for control of these and other tick vectors of disease.

PMID: 17476327 [PubMed - in process]